Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Creative Medical Technology Holdings (CELZ) over the last 17 years, with Q3 2025 value amounting to 0.98%.

  • Creative Medical Technology Holdings' Return on Capital Employed fell 1900.0% to 0.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.98%, marking a year-over-year decrease of 1900.0%. This contributed to the annual value of 0.69% for FY2024, which is 3000.0% down from last year.
  • As of Q3 2025, Creative Medical Technology Holdings' Return on Capital Employed stood at 0.98%, which was down 1900.0% from 0.79% recorded in Q2 2025.
  • Over the past 5 years, Creative Medical Technology Holdings' Return on Capital Employed peaked at 2.15% during Q2 2021, and registered a low of 0.98% during Q3 2025.
  • Its 5-year average for Return on Capital Employed is 0.34%, with a median of 0.59% in 2022.
  • As far as peak fluctuations go, Creative Medical Technology Holdings' Return on Capital Employed soared by 18700bps in 2021, and later plummeted by -24700bps in 2022.
  • Quarter analysis of 5 years shows Creative Medical Technology Holdings' Return on Capital Employed stood at 0.51% in 2021, then decreased by -15bps to 0.59% in 2022, then rose by 15bps to 0.5% in 2023, then tumbled by -78bps to 0.89% in 2024, then dropped by -10bps to 0.98% in 2025.
  • Its Return on Capital Employed stands at 0.98% for Q3 2025, versus 0.79% for Q2 2025 and 0.87% for Q1 2025.